Honeywell International Inc. Invests $35.05 Million in CME Group Inc (CME)

Honeywell International Inc. acquired a new stake in CME Group Inc (NASDAQ:CME) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 240,000 shares of the financial services provider’s stock, valued at approximately $35,052,000. CME Group makes up 1.2% of Honeywell International Inc.’s portfolio, making the stock its 25th biggest holding. Honeywell International Inc. owned 0.07% of CME Group at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Comerica Bank increased its stake in shares of CME Group by 0.4% in the 4th quarter. Comerica Bank now owns 84,159 shares of the financial services provider’s stock valued at $13,044,000 after acquiring an additional 313 shares in the last quarter. Daiwa Securities Group Inc. increased its stake in shares of CME Group by 2.5% in the 4th quarter. Daiwa Securities Group Inc. now owns 14,590 shares of the financial services provider’s stock valued at $2,131,000 after acquiring an additional 362 shares in the last quarter. ARGI Investment Services LLC increased its stake in shares of CME Group by 6.4% in the 3rd quarter. ARGI Investment Services LLC now owns 6,326 shares of the financial services provider’s stock valued at $856,000 after acquiring an additional 378 shares in the last quarter. First Capital Advisors Group LLC. increased its stake in CME Group by 8.3% during the 3rd quarter. First Capital Advisors Group LLC. now owns 5,185 shares of the financial services provider’s stock valued at $704,000 after purchasing an additional 399 shares in the last quarter. Finally, Raymond James Trust N.A. increased its stake in CME Group by 3.0% during the 3rd quarter. Raymond James Trust N.A. now owns 14,755 shares of the financial services provider’s stock valued at $2,002,000 after purchasing an additional 427 shares in the last quarter. Institutional investors own 82.63% of the company’s stock.

CME Group Inc (NASDAQ:CME) opened at $162.38 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.05 and a current ratio of 1.03. The stock has a market cap of $55,065.49, a price-to-earnings ratio of 34.11, a price-to-earnings-growth ratio of 2.10 and a beta of 0.64. CME Group Inc has a fifty-two week low of $114.82 and a fifty-two week high of $165.35.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.02. The firm had revenue of $900.00 million for the quarter, compared to the consensus estimate of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.14 EPS. sell-side analysts anticipate that CME Group Inc will post 6.32 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.72%. This is an increase from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date is Thursday, March 8th. CME Group’s payout ratio is currently 22.11%.

A number of analysts have commented on CME shares. Bank of America boosted their price target on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research note on Friday, February 2nd. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research note on Tuesday, January 2nd. Sandler O’Neill restated a “buy” rating and set a $175.00 price target on shares of CME Group in a research note on Friday, February 2nd. Barclays boosted their price target on shares of CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Finally, BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 10th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $157.00.

In other CME Group news, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total transaction of $31,982.00. Following the transaction, the director now directly owns 3,809 shares of the company’s stock, valued at approximately $609,097.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kimberly S. Taylor sold 8,125 shares of the business’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $150.00, for a total transaction of $1,218,750.00. Following the completion of the transaction, the insider now directly owns 120,590 shares in the company, valued at $18,088,500. The disclosure for this sale can be found here. Insiders have sold a total of 64,728 shares of company stock worth $9,755,257 over the last ninety days. Insiders own 0.57% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/20/honeywell-international-inc-invests-35-05-million-in-cme-group-inc-cme.html.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply